LIVLIP tab.
SUPPORTIVE AND MAINTENANCE THERAPY FOR ACUTE AND CHRONIC LIVER DISORDERS
LIVLIP as a supportive therapy during mild to moderate liver disease. Ornithine is a initial substance which starts the detoxification cycle or urea cycle, by activating the urea cycle enzymes,carbamyl tranferase and synthetase.which converts toxic ammonia into toxic urea helps the diseased liver to perform normal functions smoothly. Thus promotes detoxification means, lower elevated level of ammonia in blood (hyperammonemia) and improved the subjective symptoms of nausea and vomiting.Aspartate an essential component of citric acid cycle, which liberates energy (ATP) helps registration of damaged cells. Thus restore normal metabolic function of liver improves the general symptoms of weakness. Pancreatin contains amylase, lipase, and protease – chemicals that help to digest food. These chemicals are normally produced by the pancreas.
LIVLIP SYP.
It promotes detoxification means, lower elevated level of ammonia in blood (hyperammonemia) and improved the subjective symptoms of nausea and vomiting.Riboflavin is required for the proper development and function of the skin, lining of the digestive tract, blood cells, and many other parts of the body. Nicotinamide is a vitamin that plays an important role in the synthesis of components necessary for the production of ATP.
LIVLIP INJ.
It converts toxic ammonia into toxic urea helps the diseased liver to perform normal functions smoothly. Aspartate an essential component of citric acid cycle, which liberates energy (ATP) helps registration of damaged cells. Thus restore normal metabolic function of liver improves the general symptoms of weakness.
INDICATIONS:
Alcoholic liver damage
Fatty liver
Hepatitis
Post hepatitis convalescence
Cirrhosis
Prophylaxis and treatment of drug induced hepatitis.
Mr.K Ragunathan, (48)
Chairman
The pharmaceutical industry needs a high level of consistency in terms of quality of drugs and medicines they manufacture and continue to strive for honouring commitments to clients. Globally there have been concerted efforts to monitor quality and regulate pharma operations for quality health care being extended to the target population.
Towards this end, we at Lipak India are constantly evolving to newer heights by placing our focus on Products, Processes and People as central themes to guide our business philosophy. With Innovation being a value driver, our strategic planning started in early 2011 with an ideation session analysing Lipak India's current strengths, weaknesses, opportunities and threats. We will be continuing our dialogue on strategic planning throughout the next several months, looking at financial health, research and development focus, management structure, operational efficiency, risk management, stakeholder communication, shareholder wealth creation and corporate social responsibility.
By the end of this process, we will be credited with a clear road map that will help us navigate smoothly through the challenges ahead.
Over the last decade many pharma organisations across India have started adopting various excellence initiatives. These initiatives are supposed to aid organisations in creating value and help face the challenging business needs. Let me hasten to add that Lipak India has seized this opportunity by adopting certain companywide initiatives such as management restructuring, venturing into newer business portfolios, enterprise resource planning, setting up HR governing council and adoption of operational excellence cell apart from culling out task force teams in quality and R&D with a view to provide the best pharma solutions to our esteemed clients
Lipak India stands today as one of the few distinguished vertically integrated pharmaceutical companies with a robust product portfolio produced out of our own approved manufacturing facilities, both in the areas of API and Formulations, with enviable longstanding business partnerships.
Over the years, we have grown from strength to strength and our global team of more than 9,500 scientists, technicians, sales, marketing, financial, manufacturing, quality, administrative and other business professional’s work together to achieve our global mission - "Committed to healthier life”.
We are sure that with the continued support and patronage of all our stakeholders, Lipak India will continue to enjoy the saga of business excellence in the healthcare sector in the coming periods, cutting across geographical boundaries.
We are Lipak India Ltd. “A global pharmaceutical company with great commitment to a healthier life".
